Skip to Content

73 Results Found

  • Communication
  • Open Access
10 Citations
3,560 Views
8 Pages

Protein-Based Delivery Systems for Anticancer Metallodrugs: Structure and Biological Activity of the Oxaliplatin/β-Lactoglobulin Adduct

  • Daria Maria Monti,
  • Domenico Loreto,
  • Ilaria Iacobucci,
  • Giarita Ferraro and ,
  • Alessandro Pratesi,
  • Luigi D’Elia,
  • Maria Monti and
  • Antonello Merlino
  • + 3 authors+ 0 author

30 March 2022

β-lactoglobulin is the major component of whey. Here, the adduct formed upon the reaction of the protein with oxaliplatin (OXA) has been prepared, structurally characterized by X-ray crystallography and electrospray ionization–mass spectro...

(This article belongs to the Special Issue Selected Papers from the 7th International Electronic Conference on Medicinal Chemistry (ECMC2021))
  • Review
  • Open Access
41 Citations
5,574 Views
27 Pages

Computational Studies of Au(I) and Au(III) Anticancer MetalLodrugs: A Survey

  • Iogann Tolbatov,
  • Alessandro Marrone,
  • Cecilia Coletti and
  • Nazzareno Re

15 December 2021

Owing to the growing hardware capabilities and the enhancing efficacy of computational methodologies, computational chemistry approaches have constantly become more important in the development of novel anticancer metallodrugs. Besides traditional Pt...

(This article belongs to the Special Issue Feature Review Papers in Physical Chemistry)
  • Review
  • Open Access
39 Citations
8,516 Views
19 Pages

Nano-Based Systems and Biomacromolecules as Carriers for Metallodrugs in Anticancer Therapy

  • Mina Poursharifi,
  • Marek T. Wlodarczyk and
  • Aneta J. Mieszawska

Since the discovery of cisplatin and its potency in anticancer therapy, the development of metallodrugs has been an active area of research. The large choice of transition metals, oxidation states, coordinating ligands, and different geometries, allo...

(This article belongs to the Special Issue Unconventional Anticancer Metallodrugs and Strategies to Improve their Pharmacological Profile)
  • Review
  • Open Access
92 Citations
14,689 Views
23 Pages

For more than 100 years metal complexes have been extensively used in therapy and since the discovery of cisplatin the research in this field has expanded exponentially. The scientific community is always in search of new alternatives to platinum com...

(This article belongs to the Special Issue Tumor Inhibiting Metal Complexes)
  • Review
  • Open Access
26 Citations
5,558 Views
45 Pages

Anticancer Activity of Metallodrugs and Metallizing Host Defense Peptides—Current Developments in Structure-Activity Relationship

  • Celia María Curieses Andrés,
  • José Manuel Pérez de la Lastra,
  • Elena Bustamante Munguira,
  • Celia Andrés Juan and
  • Eduardo Pérez-Lebeña

This article provides an overview of the development, structure and activity of various metal complexes with anti-cancer activity. Chemical researchers continue to work on the development and synthesis of new molecules that could act as anti-tumor dr...

(This article belongs to the Section Bioactives and Nutraceuticals)
  • Review
  • Open Access
32 Citations
5,104 Views
36 Pages

Relevance of Fluorinated Ligands to the Design of Metallodrugs for Their Potential Use in Cancer Treatment

  • José C. Páez-Franco,
  • Miriam R. Zermeño-Ortega,
  • Carmen Myriam de la O-Contreras,
  • Daniel Canseco-González and ,
  • Jesus R. Parra-Unda,
  • Alcives Avila-Sorrosa,
  • Raúl G. Enríquez,
  • Juan M. Germán-Acacio and
  • David Morales-Morales
  • + 4 authors+ 0 author

Fluorination of pharmaceutical agents has afforded crucial modifications to their pharmacological profiles, leading to important advances in medicinal chemistry. On the other hand, metallodrugs are considered to be valuable candidates in the treatmen...

(This article belongs to the Special Issue Metallodrugs for Targeted Cancer Therapy)
  • Article
  • Open Access
32 Citations
6,143 Views
25 Pages

Stimulation of Sulfonamides Antibacterial Drugs Activity as a Result of Complexation with Ru(III): Physicochemical and Biological Study

  • Paulina Spisz,
  • Agnieszka Chylewska,
  • Aleksandra Królicka,
  • Sandra Ramotowska and ,
  • Aleksandra Dąbrowska and
  • Mariusz Makowski
  • + 1 author+ 0 author

15 December 2021

Antibiotic resistance is a global problem, and one promising solution to overcome this issue is using metallodrugs, which are drugs containing metal ions and ligands. These complexes are superior to free ligands in various characteristics including a...

(This article belongs to the Section Biochemistry)
  • Article
  • Open Access
25 Citations
4,014 Views
11 Pages

Impact of the Metal Center and Leaving Group on the Anticancer Activity of Organometallic Complexes of Pyridine-2-carbothioamide

  • Jahanzaib Arshad,
  • Kelvin K. H. Tong,
  • Sanam Movassaghi,
  • Tilo Söhnel and ,
  • Stephen M. F. Jamieson,
  • Muhammad Hanif and
  • Christian G. Hartinger
  • + 2 authors+ 0 author

5 February 2021

RuII(cym)Cl (cym = η6-p-cymene) complexes of pyridinecarbothioamides have shown potential for development as orally active anticancer metallodrugs, underlined by their high selectivity towards plectin as the molecular target. In order to investigate...

(This article belongs to the Special Issue Cancer and Tuberculosis Drug Discovery: A Theme Issue in Honor of Prof. William A. Denny)
  • Article
  • Open Access
8 Citations
2,424 Views
10 Pages

23 February 2024

The targeting of human thioredoxin reductase is widely recognized to be crucially involved in the anticancer properties of several metallodrugs, including Au(I) complexes. In this study, the mechanism of reaction between a set of five N-heterocyclic...

(This article belongs to the Special Issue Techniques and Strategies in Drug Design and Discovery, 2nd Edition)
  • Editorial
  • Open Access
9 Citations
3,718 Views
4 Pages

For the past 41 years, metal-based drugs have been widely used for the treatment of cancer [...]

(This article belongs to the Special Issue Unconventional Anticancer Metallodrugs and Strategies to Improve their Pharmacological Profile)
  • Article
  • Open Access
8 Citations
6,447 Views
25 Pages

Fluorescent Vitamin B12–Platinum(II) Derivatives as Potential Metallotheranostic Agents for the Treatment and Imaging of Tumors

  • Rozan Mehder,
  • Elena de la Torre-Rubio,
  • Isabel de la Cueva-Alique,
  • Ciaran O’Malley and ,
  • Adrián Pérez-Redondo,
  • Lourdes Gude,
  • Eva Royo and
  • Luca Ronconi
  • + 3 authors+ 0 author

Vitamin B12 (cyanocobalamin) is an essential nutrient with very low bioavailability. Compared with normal cells, tumor cells show an increased demand for vitamin B12 to support their abnormal proliferation, which is a feature that can be exploited fo...

(This article belongs to the Section Bioinorganic Chemistry)
  • Article
  • Open Access
18 Citations
4,258 Views
18 Pages

Lipid Status of A2780 Ovarian Cancer Cells after Treatment with Ruthenium Complex Modified with Carbon Dot Nanocarriers: A Multimodal SR-FTIR Spectroscopy and MALDI TOF Mass Spectrometry Study

  • Maja D. Nešić,
  • Tanja Dučić,
  • Manuel Algarra,
  • Iva Popović and ,
  • Milutin Stepić,
  • Mara Gonçalves and
  • Marijana Petković
  • + 2 authors+ 0 author

24 February 2022

In the last decade, targeting membrane lipids in cancer cells has been a promising approach that deserves attention in the field of anticancer drug development. To get a comprehensive understanding of the effect of the drug [Ru(η5-Cp)(PPh3)2CN] (...

(This article belongs to the Section Molecular Cancer Biology)
  • Article
  • Open Access
26 Citations
4,630 Views
18 Pages

Selective Anticancer and Antimicrobial Metallodrugs Based on Gold(III) Dithiocarbamate Complexes

  • Elisa Abás,
  • Diego Aguirre-Ramírez,
  • Mariano Laguna and
  • Laura Grasa

26 November 2021

New dithiocarbamate cycloaurated complexes have been synthesized and their physicochemical and in vitro antitumor properties have been evaluated. All the performed studies highlighted good transport through the blood and biodistribution, according to...

(This article belongs to the Special Issue Gold and Silver Complexes in the Treatment of Diseases)
  • Review
  • Open Access
4 Citations
2,067 Views
25 Pages

The Role of Metallodrugs in Enhancing Neuroendocrine Neoplasm Therapies: The Promising Anticancer Potential of Ruthenium-Based Complexes

  • Erika Stefàno,
  • Federica De Castro,
  • Asjad Ali,
  • Michele Benedetti and
  • Francesco Paolo Fanizzi

21 September 2025

Neuroendocrine neoplasms (NENs) represent a small and heterogeneous group of tumors that share a common phenotype, originating from cells within the endocrine and nervous systems. Metallodrugs have had a significant impact on the treatment of NENs, a...

(This article belongs to the Special Issue Metal-Based Drugs: Past, Present and Future, 3rd Edition)
  • Article
  • Open Access
15 Citations
4,487 Views
22 Pages

Dual Anticancer and Antibacterial Properties of Silica-Based Theranostic Nanomaterials Functionalized with Coumarin343, Folic Acid and a Cytotoxic Organotin(IV) Metallodrug

  • Maider Ugalde-Arbizu,
  • John Jairo Aguilera-Correa,
  • Victoria García-Almodóvar,
  • Karina Ovejero-Paredes and ,
  • Diana Díaz-García,
  • Jaime Esteban,
  • Paulina L. Páez,
  • Sanjiv Prashar,
  • Eider San Sebastian and
  • Santiago Gómez-Ruiz
  • + 6 authors+ 1 author

Five different silica nanoparticles functionalized with vitamin B12, a derivative of coumarin found in green plants and a minimum content of an organotin(IV) fragment (1-MSN-Sn, 2-MSN-Sn, 2-SBA-Sn, 2-FSPm-Sn and 2-FSPs-Sn), were identified as excelle...

(This article belongs to the Special Issue Drug Delivery of Natural Active Principles: Focus on Topical and Oral Applications)
  • Article
  • Open Access
25 Citations
5,847 Views
21 Pages

The DACHPtCl2 compound (trans-(R,R)-1,2-diaminocyclohexanedichloroplatinum(II)) is a potent anticancer drug with a broad spectrum of activity and is less toxic than oxaliplatin (trans-l-diaminocyclohexane oxalate platinum II), with which it shares th...

(This article belongs to the Special Issue Dendrimers in Medicine: Theme Issue Honoring Professor Jean-Pierre Majoral on His 80th Birthday)
  • Article
  • Open Access
11 Citations
3,108 Views
11 Pages

Synthesis and Preclinical Evaluation of Radiolabeled [103Ru]BOLD-100

  • Barbara Happl,
  • Marie Brandt,
  • Theresa Balber,
  • Katarína Benčurová and ,
  • Zeynep Talip,
  • Alexander Voegele,
  • Petra Heffeter,
  • Wolfgang Kandioller,
  • Nicholas P. Van der Meulen and
  • Thomas L. Mindt
  • + 8 authors+ 3 authors

The first-in-class ruthenium-based chemotherapeutic agent BOLD-100 (formerly IT-139, NKP-1339, KP1339) is currently the subject of clinical evaluation for the treatment of gastric, pancreatic, colorectal and bile duct cancer. A radiolabeled version o...

(This article belongs to the Section Drug Targeting and Design)
  • Review
  • Open Access
92 Citations
9,584 Views
40 Pages

Ferrocene has been the most used organometallic moiety introduced in organic and bioinorganic drugs to cure cancers and various other diseases. Following several pioneering studies, two real breakthroughs occurred in 1996 and 1997. In 1996, Jaouen et...

(This article belongs to the Special Issue Dendrimers: A Themed Issue in Honor of Professor Donald A. Tomalia on the Occasion of His 85th Birthday for His Outstanding Achievements in Advancing the Field of Dendrimers)
  • Review
  • Open Access
8 Citations
2,601 Views
14 Pages

28 April 2024

Metallodrugs are an important group of medicinal agents used for the treatment of various diseases ranging from cancers to viral, bacterial, and parasitic diseases. Their distinctive features include the availability of a metal centre, redox activity...

  • Article
  • Open Access
13 Citations
3,956 Views
20 Pages

Cytostatic Action of Novel Histone Deacetylase Inhibitors in Androgen Receptor-Null Prostate Cancer Cells

  • Zohaib Rana,
  • Joel D. A. Tyndall,
  • Muhammad Hanif,
  • Christian G. Hartinger and
  • Rhonda J. Rosengren

29 January 2021

Androgen receptor (AR)-null prostate tumors have been observed in 11–24% of patients. Histone deacetylases (HDACs) are overexpressed in prostate tumors. Therefore, HDAC inhibitors (Jazz90 and Jazz167) were examined in AR-null prostate cancer ce...

(This article belongs to the Special Issue Cancer Translational Biomarkers and Targeted Therapies)
  • Article
  • Open Access
13 Citations
3,896 Views
11 Pages

Arsenoplatin-Ferritin Nanocage: Structure and Cytotoxicity

  • Giarita Ferraro,
  • Alessandro Pratesi,
  • Damiano Cirri,
  • Paola Imbimbo and ,
  • Daria Maria Monti,
  • Luigi Messori and
  • Antonello Merlino
  • + 2 authors+ 0 author

13 February 2021

Arsenoplatin-1 (AP-1), the prototype of a novel class of metallodrugs containing a PtAs(OH)2 core, was encapsulated within the apoferritin (AFt) nanocage. UV-Vis absorption spectroscopy and inductively coupled plasma-atomic emission spectroscopy meas...

(This article belongs to the Special Issue Metallodrugs: Mechanisms of Action, Molecular Targets and Biological Activity)
  • Review
  • Open Access
44 Citations
5,758 Views
20 Pages

Gold (III) Derivatives in Colon Cancer Treatment

  • Agata Gurba,
  • Przemysław Taciak,
  • Mariusz Sacharczuk,
  • Izabela Młynarczuk-Biały and ,
  • Magdalena Bujalska-Zadrożny and
  • Jakub Fichna
  • + 1 author+ 0 author

Cancer is one of the leading causes of morbidity and mortality worldwide. Colorectal cancer (CRC) is the third most frequently diagnosed cancer in men and the second in women. Standard patterns of antitumor therapy, including cisplatin, are ineffecti...

(This article belongs to the Special Issue Novel Strategies in the Development of New Therapies, Drug Substances and Drug Carriers)
  • Article
  • Open Access
17 Citations
3,398 Views
14 Pages

Evaluation of Auranofin Loading within Ferritin Nanocages

  • Rosanna Lucignano,
  • Alessandro Pratesi,
  • Paola Imbimbo,
  • Daria Maria Monti and ,
  • Delia Picone,
  • Luigi Messori,
  • Giarita Ferraro and
  • Antonello Merlino
  • + 3 authors+ 0 author

16 November 2022

Auranofin (AF), a gold(I) compound that is currently used for the treatment of rheumatoid arthritis and is in clinical trials for its promising anticancer activity, was encapsulated within the human H-chain and the horse spleen ferritin nanocages usi...

(This article belongs to the Special Issue Metallodrugs: Mechanisms of Action, Molecular Targets and Biological Activity 2.0)
  • Article
  • Open Access
43 Citations
5,084 Views
16 Pages

Cytotoxic Activity of Organotin(IV) Derivatives with Triazolopyrimidine Containing Exocyclic Oxygen Atoms

  • Alessandro Attanzio,
  • Simone D’Agostino,
  • Rosalia Busà,
  • Anna Frazzitta and ,
  • Simona Rubino,
  • Maria Assunta Girasolo,
  • Piera Sabatino and
  • Luisa Tesoriere
  • + 3 authors+ 0 author

15 February 2020

In this study cytotoxicity of organotin(IV) compounds with 1,2,4-triazolo[1,5-a]pyrimidines, Me3Sn(5tpO) (1), n-Bu3Sn(5tpO) (2), Me3Sn(mtpO) (3), n-Bu3Sn(mtpO) (4), n-Bu3Sn(HtpO2) (5), Ph3Sn(HtpO2) (6) where 5HtpO = 4,5-dihydro-5-oxo-[1,2,4]triazolo-...

(This article belongs to the Special Issue Metal-Based Drugs)
  • Review
  • Open Access
24 Citations
9,013 Views
30 Pages

Evaluating Ligand Modifications of the Titanocene and Auranofin Moieties for the Development of More Potent Anticancer Drugs

  • Lauren Fernández-Vega,
  • Valeria A. Ruiz Silva,
  • Tania M. Domínguez-González,
  • Sebastián Claudio-Betancourt and ,
  • Rafael E. Toro-Maldonado,
  • Luisa C. Capre Maso,
  • Karina Sanabria Ortiz,
  • Jean A. Pérez-Verdejo,
  • Janeishly Román González and
  • Arthur D. Tinoco
  • + 12 authors+ 7 authors

Over time platinum-based anticancer drugs have dominated the market, but their side effects significantly impact the quality of life of patients. Alternative treatments are being developed all over the world. The titanocene and auranofin families of...

(This article belongs to the Section Coordination Chemistry)
  • Review
  • Open Access
117 Citations
9,748 Views
19 Pages

25 December 2019

Although organic compounds account for more than 99% of currently approved clinical drugs, the established clinical use of cisplatin in cancer or auranofin in rheumatoid arthritis have paved the way to several research initiatives to identify metal-b...

(This article belongs to the Special Issue Metal-Based Drugs: Updates and Perspectives)
  • Article
  • Open Access
1 Citations
1,435 Views
13 Pages

Multitargeting Pt(IV) Anticancer Prodrugs Bearing Mono- and Bis-Probenecid Ligands in Axial Positions: Synthesis and Evaluation of Biological Activity

  • Panxing Qiu,
  • Yu Zhang,
  • Yang Dou,
  • Zhijin Cheng and ,
  • Xiaoqin Wu,
  • Silong Zhang,
  • Fuyi Wang and
  • Kui Wu
  • + 3 authors+ 0 author

27 February 2026

Background: To battle the side effects of anticancer Pt(II) drug cisplatin, the development of photoactivatable and/or intracellular reduction-activatable Pt(IV) prodrugs has become a promising strategy. Methods: Herein, two novel Pt(IV) prodrugs, na...

(This article belongs to the Special Issue Adjuvant Therapies for Cancer Treatment: 2nd Edition)
  • Article
  • Open Access
1 Citations
2,871 Views
23 Pages

Preliminary Study of the Cytotoxic Activity of Pd(II) and Pt(II) Complexes Bearing P-N ligands Derived from Aminoalcohols

  • Jair Isai Ortega-Gaxiola,
  • Juan S. Serrano-García,
  • Andrés Amaya-Flórez,
  • Jordi R. Galindo and ,
  • Antonino Arenaza-Corona,
  • Simón Hernández-Ortega,
  • Teresa Ramírez-Apan,
  • Jorge Alí-Torres,
  • Adrián L. Orjuela and
  • David Morales-Morales
  • + 8 authors+ 3 authors

2 December 2025

Iminophosphine ligands find extensive applications in homogeneous catalysis; however, their potential antitumor activity is currently being explored. Including biologically active moieties, such as aminoalcohols, could enhance this activity further....

(This article belongs to the Special Issue Editorial Board Members’ Collection Series in “Featuring Ligands and Their Applications in Coordination Chemistry”, 2nd Edition)
  • Review
  • Open Access
11 Citations
2,484 Views
47 Pages

Recent Advances in the Development of Metal-Glycoconjugates for Medicinal Applications

  • Federica Brescia,
  • Ioannis Titilas,
  • Simona Cacciapuoti and
  • Luca Ronconi

29 August 2025

Rapidly proliferating tumor cells exhibit elevated demands for nutrients and energy to support their uncontrolled growth, with glucose serving as a key metabolic substrate. Glucose is transported into cells via facilitated diffusion mediated by gluco...

(This article belongs to the Special Issue Recent Advances in Development of Small Molecules to Fight Cancer—2nd Edition)
  • Review
  • Open Access
65 Citations
8,844 Views
24 Pages

Anticancer Half-Sandwich Rhodium(III) Complexes

  • Klaudia Máliková,
  • Lukáš Masaryk and
  • Pavel Štarha

Platinum-based anticancer drugs are most likely the most successful group of bioinorganic compounds. Their apparent disadvantages have led to the development of anticancer compounds of other noble metals, resulting in several ruthenium-based drugs wh...

(This article belongs to the Section Organometallic Chemistry)
  • Perspective
  • Open Access
17 Citations
4,435 Views
19 Pages

7 November 2022

Globally, an estimated 9 million deaths per year are caused by human exposure to environmental pollutants, including toxic metal(loid) species. Since pollution is underestimated in calculations of the global burden of disease, the actual number of po...

(This article belongs to the Special Issue Recent Progress in Coordination Chemistry)
  • Review
  • Open Access
2 Citations
4,700 Views
32 Pages

The Role of Vanadium in Metallodrugs Design and Its Interactive Profile with Protein Targets

  • Otávio Augusto Chaves,
  • Francisco Mainardi Martins,
  • Carlos Serpa and
  • Davi Fernando Back

Metallodrugs represent a critical area of medicinal chemistry with the potential to address a wide range of diseases. Their design requires a multidisciplinary approach, combining principles of inorganic chemistry, pharmacology, and molecular biology...

(This article belongs to the Special Issue Feature Papers in Future Pharmacology 2024)
  • Review
  • Open Access
10 Citations
4,176 Views
26 Pages

Cancer 3D Models for Metallodrug Preclinical Testing

  • Diogo M. Engrácia,
  • Catarina I. G. Pinto and
  • Filipa Mendes

Despite being standard tools in research, the application of cellular and animal models in drug development is hindered by several limitations, such as limited translational significance, animal ethics, and inter-species physiological differences. In...

(This article belongs to the Special Issue Metals and Cancer)
  • Article
  • Open Access
2 Citations
3,056 Views
13 Pages

Exploring the Impact of Head Group Modifications on the Anticancer Activities of Fatty-Acid-like Platinum(IV) Prodrugs: A Structure–Activity Relationship Study

  • Man Kshetri,
  • Wjdan Jogadi,
  • Suha Alqarni,
  • Payel Datta and ,
  • May Cheline,
  • Arpit Sharma,
  • Tyler Betters,
  • Deonya Broyles and
  • Yao-Rong Zheng
  • + 4 authors+ 0 author

27 August 2023

We conducted the first comprehensive investigation on the impact of head group modifications on the anticancer activities of fatty-acid-like Pt(IV) prodrugs (FALPs), which are a class of platinum-based metallodrugs that target mitochondria. We create...

(This article belongs to the Special Issue Emerging Topics in Metal Complexes: Pharmacological Activity)
  • Review
  • Open Access
42 Citations
8,738 Views
25 Pages

Recent Advances in Bioconjugated Transition Metal Complexes for Cancer Therapy

  • Enrica Bortolamiol,
  • Fabiano Visentin and
  • Thomas Scattolin

29 April 2023

The introduction of biologically relevant organic moieties in the coordination sphere of transition metal complexes has recently become a well-established strategy to increase the selectivity and biocompatibility of metallodrugs. In this review, the...

(This article belongs to the Special Issue Bioactive Compounds from Various Sources: Beneficial Effects and Technological Applications II)
  • Review
  • Open Access
45 Citations
8,378 Views
32 Pages

Complexes of Ruthenium(II) as Promising Dual-Active Agents against Cancer and Viral Infections

  • Assunta D’Amato,
  • Annaluisa Mariconda,
  • Domenico Iacopetta,
  • Jessica Ceramella and ,
  • Alessia Catalano,
  • Maria Stefania Sinicropi and
  • Pasquale Longo
  • + 2 authors+ 0 author

15 December 2023

Poor responses to medical care and the failure of pharmacological treatment for many high-frequency diseases, such as cancer and viral infections, have been widely documented. In this context, numerous metal-based substances, including cisplatin, aur...

(This article belongs to the Section Medicinal Chemistry)
  • Article
  • Open Access
8 Citations
3,581 Views
32 Pages

New Ruthenium-Cyclopentadienyl Complexes Affect Colorectal Cancer Hallmarks Showing High Therapeutic Potential

  • Ana Rita Brás,
  • Pedro Fernandes,
  • Tiago Moreira,
  • Julia Morales-Sanfrutos and ,
  • Eduard Sabidó,
  • Alexandra M. M. Antunes,
  • Andreia Valente and
  • Ana Preto
  • + 3 authors+ 0 author

Colorectal cancer (CRC) is among the most deadly cancers worldwide. Current therapeutic strategies have low success rates and several side effects. This relevant clinical problem requires the discovery of new and more effective therapeutic alternativ...

(This article belongs to the Special Issue Novel Anticancer Strategies, 3rd Edition)
  • Article
  • Open Access
16 Citations
3,810 Views
13 Pages

Peptide-Templated Gold Clusters as Enzyme-Like Catalyst Boost Intracellular Oxidative Pressure and Induce Tumor-Specific Cell Apoptosis

  • Ya Zhang,
  • Xiangchun Zhang,
  • Qing Yuan,
  • Wenchao Niu and ,
  • Chunyu Zhang,
  • Jiaojiao Li,
  • Zhesheng He,
  • Yuhua Tang,
  • Xiaojun Ren and
  • Xueyun Gao
  • + 8 authors+ 3 authors

12 December 2018

Anticancer metallodrugs that aim to physiological characters unique to tumor microenvironment are expected to combat drug tolerance and side-effects. Recently, owing to the fact that reactive oxygen species’ is closely related to the developmen...

  • Review
  • Open Access
3 Citations
1,006 Views
47 Pages

The design of multitargeted drug candidates has recently emerged as a highly attractive area of research. Numerous heterometallic compounds have been developed to enhance both the biological efficacy and physicochemical properties of monometallic met...

(This article belongs to the Section Drug Discovery, Development and Delivery)
  • Proceeding Paper
  • Open Access
5 Citations
2,744 Views
4 Pages

Studies of the pharmacological action of vanadium compounds have shown that vanadium has been arousing interest as a potential candidate for therapeutic applications. Polyoxovanadates (POVs) emerge from polyoxometalatates (POMs) and are responsible f...

(This article belongs to the Proceedings of Biosystems in Toxicology and Pharmacology—Current Challenges)
  • Feature Paper
  • Article
  • Open Access
17 Citations
4,078 Views
19 Pages

Interaction with Blood Proteins of a Ruthenium(II) Nitrofuryl Semicarbazone Complex: Effect on the Antitumoral Activity

  • Bruno Demoro,
  • Andreia Bento-Oliveira,
  • Fernanda Marques,
  • João Costa Pessoa and ,
  • Lucía Otero,
  • Dinorah Gambino,
  • Rodrigo F. M. de Almeida and
  • Ana Isabel Tomaz
  • + 3 authors+ 0 author

7 August 2019

The steady rise in the cancer burden and grim statistics set a vital need for new therapeutic solutions. Given their high efficiency, metallodrugs are quite appealing in cancer chemotherapy. This work examined the anticancer activity of an anti-trypa...

(This article belongs to the Section Organometallic Chemistry)
  • Article
  • Open Access
23 Citations
4,799 Views
12 Pages

A Combination of Rosa Canina Extracts and Gold Complex Favors Apoptosis of Caco-2 Cells by Increasing Oxidative Stress and Mitochondrial Dysfunction

  • Inés Mármol,
  • Nerea Jiménez-Moreno,
  • Carmen Ancín-Azpilicueta,
  • Jesús Osada and ,
  • Elena Cerrada and
  • María Jesús Rodríguez-Yoldi
  • + 1 author+ 0 author

24 December 2019

Given the alarming increase in colorectal cancer (CRC) worldwide, novel therapies are urgently needed. Plant-derived extracts have gained considerable interest in the last years due to their strong anticancer effect mediated by their unique bioactive...

(This article belongs to the Section Health Outcomes of Antioxidants and Oxidative Stress)
  • Review
  • Open Access
37 Citations
5,039 Views
30 Pages

Breast Cancer Chemotherapeutic Options: A General Overview on the Preclinical Validation of a Multi-Target Ruthenium(III) Complex Lodged in Nucleolipid Nanosystems

  • Maria Grazia Ferraro,
  • Marialuisa Piccolo,
  • Gabriella Misso,
  • Francesco Maione and ,
  • Daniela Montesarchio,
  • Michele Caraglia,
  • Luigi Paduano,
  • Rita Santamaria and
  • Carlo Irace
  • + 4 authors+ 0 author

5 June 2020

In this review we have showcased the preclinical development of original amphiphilic nanomaterials designed for ruthenium-based anticancer treatments, to be placed within the current metallodrugs approach leading over the past decade to advanced mult...

(This article belongs to the Special Issue Metabolic Rewiring in Cancer Cells: From Tumor Onset to Novel Therapies)
  • Feature Paper
  • Article
  • Open Access
37 Citations
7,476 Views
17 Pages

Poly(alkylidenimine) Dendrimers Functionalized with the Organometallic Moiety [Ru(η5-C5H5)(PPh3)2]+ as Promising Drugs Against Cisplatin-Resistant Cancer Cells and Human Mesenchymal Stem Cells

  • Marisol Gouveia,
  • João Figueira,
  • Manuel G. Jardim,
  • Rita Castro and ,
  • Helena Tomás,
  • Kari Rissanen and
  • João Rodrigues
  • + 2 authors+ 0 author

Here and for the first time, we show that the organometallic compound [Ru(η5-C5H5)(PPh3)2Cl] (RuCp) has potential to be used as a metallodrug in anticancer therapy, and further present a new approach for the cellular delivery of the [Ru(η5-C5...

(This article belongs to the Special Issue Dendrimers: A Themed Issue in Honor of Professor Donald A. Tomalia on the Occasion of His 80th Birthday)
  • Feature Paper
  • Article
  • Open Access
17 Citations
4,525 Views
23 Pages

Ternary Copper Complex of L-Glutamine and Phenanthroline as Counterions of Cyclo-Tetravanadate Anion: Experimental–Theoretical Characterization and Potential Antineoplastic Activity

  • Nidia D. Corona-Motolinia,
  • Beatriz Martínez-Valencia,
  • Lisset Noriega,
  • Brenda L. Sánchez-Gaytán and ,
  • Angel Mendoza,
  • Francisco J. Meléndez-Bustamante,
  • María Eugenia Castro and
  • Enrique González-Vergara
  • + 3 authors+ 0 author

27 September 2021

Over the last decade, therapeutic metallodrugs have become substantially effective in the treatment of cancer. Thus, developing new effective anticancer drugs is a significant research area against the continuing increase in cancers worldwide. In the...

(This article belongs to the Special Issue The Biological Applications of Metals and Metal Complexes)
  • Article
  • Open Access
4 Citations
2,723 Views
12 Pages

Interaction of Phenanthroline-Containing Copper Complexes with Model Phospholipid Membranes

  • Priscilla Freddi,
  • Natalia Alvarez,
  • Gianella Facchin and
  • Antonio J. Costa-Filho

26 November 2024

Medicinal Inorganic Chemistry has provided oncology with metallodrugs for cancer treatment, including several promising candidate drugs. In particular, copper(II) coordination compounds with phenanthroline stand out as potential anticancer agents. In...

(This article belongs to the Special Issue Evaluation of the Potential Biological Activity of Metallo-Drugs)
  • Review
  • Open Access
10 Citations
3,473 Views
10 Pages

Anti-Inflammatory Mechanisms of Novel Synthetic Ruthenium Compounds

  • Thanasekaran Jayakumar,
  • Joen-Rong Sheu,
  • Chih-Wei Hsia,
  • Periyakali Saravana Bhavan and
  • Chao-Chien Chang

28 October 2021

Inflammation is the primary biological reaction to induce severe infection or injury in the immune system. Control of different inflammatory cytokines, such as nitric oxide (NO), interleukins (IL), tumor necrosis factor alpha-(TNF-α), noncytokine med...

(This article belongs to the Section Applied Biosciences and Bioengineering)
  • Review
  • Open Access
47 Citations
7,988 Views
22 Pages

NSAID-Based Coordination Compounds for Biomedical Applications: Recent Advances and Developments

  • Ariana C. F. Santos,
  • Luís P. G. Monteiro,
  • Adriana C. C. Gomes,
  • Fátima Martel and ,
  • Teresa M. Santos and
  • Bárbara J. M. Leite Ferreira
  • + 1 author+ 0 author

After the serendipitous discovery of cisplatin, a platinum-based drug with chemotherapeutic effects, an incredible amount of research in the area of coordination chemistry has been produced. Other transition metal compounds were studied, and several...

(This article belongs to the Special Issue Novel Metal Coordination Complexes for Biomedical Applications)
  • Article
  • Open Access
4 Citations
1,898 Views
21 Pages

Metabolomic Effects and Their Relationship with Intracellular/Extracellular Concentrations of Casiopeinas® in Triple-Negative Mesenchymal Breast Cancer

  • Karen Resendiz-Acevedo,
  • Martha E. García-Aguilera,
  • Araceli Tovar-Tovar,
  • Nuria Esturau-Escofet and
  • Lena Ruiz-Azuara

8 September 2025

Metal-based compounds, known as metallodrugs, offer promising alternatives for cancers with limited treatment options, such as triple-negative breast cancer (TNBC). Casiopeinas®, a family of copper-based compounds, have shown anticancer and antip...

(This article belongs to the Section Molecular Oncology)
  • Article
  • Open Access
14 Citations
3,536 Views
14 Pages

Anticancer Activity, Reduction Mechanism and G-Quadruplex DNA Binding of a Redox-Activated Platinum(IV)–Salphen Complex

  • Vincenzo Vigna,
  • Stefano Scoditti,
  • Angelo Spinello,
  • Gloria Mazzone and
  • Emilia Sicilia

8 December 2022

Aiming at reducing the unselective cytotoxicity of Pt(II) chemotherapeutics, a great deal of effort has been concentrated into the design of metal-containing drugs with different anticancer mechanisms of action. Inert Pt(IV) prodrugs have been propos...

(This article belongs to the Special Issue Metal-Based Complexes in Cancer)

of 2